Sample Preparation Market: Current Analysis and Forecast (2022-2028)

Sample Preparation Market: Current Analysis and Forecast (2022-2028)

Sample preparation enables more reliable identification and quantification of an analyte from a biological sample. The analyte is extracted, from sample constituents that might interfere with the subsequent analysis. The rising demand for sample preparation products from the biopharmaceutical and bioprocess industries attributes to the market growth of sample preparation. Furthermore, the rapidly rising chronic diseases are responsible for the surging demand for effective medicines and are also an important factor that is catalyzing the market dynamics of sample preparation. According to the CDC, in 2022, six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes.

The Sample Preparation Market is expected to grow at a steady rate of around 6.5%. The rising focus on minimizing the contamination of drugs and human consumables is the major factor in the growth of sample preparation. The key players are actively investing in research and development, which is also having a positive impact on the market’s growth. For instance, in June 2022, Thermo Fisher Scientific showcased the AccelerOme Automated Sample Preparation Platform during the 70th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, held during June 5-9, 2022.

• Based on product, the market is segmented into instruments, consumables, and kits. The kits held a significant share of the market in 2021. This is mainly due to the increasing demand for DNA and RNA sampling with the rise in research and development activities, testing, and diagnosis. For instance, Siemens Healthcare GmBH offers Multistix 10 SG Reagent Strips for diagnosis of UTI, diabetes, and kidney diseases.
• On the basis of application, the market is categorized into proteomics, genomics, epigenomics, and others. Among these, genomics is expected to grow with a significant CAGR during the forecast period. The genomic analysis helps in the discovery of several new drug discovery targets, and when additional targets are identified, medicines can be developed with higher selectivity than was previously achievable using conventional pharmacological techniques that drive the growth of the segment.
• Based on the end user, the sample preparation market has been classified into pharmaceutical, biotechnology, molecular diagnostics, and others. Among these, the pharmaceutical is expected to grow with a significant CAGR during the forecast period. This is mainly due to the rising demand for efficient medicines and the development of new drugs. This is due to the rising prevalence of chronic diseases. According to the World Health Organization, in 2022, the noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally.
• For a better understanding of the market adoption of the sample preparation industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to grow at a substantial CAGR during the forecast period. The demand for technological advancement coupled with the increasing demand for genomics and proteomics research. Also, the increasing prevalence of infectious diseases, which require early diagnosis is creating the opportunity for the biotechnology industry players to produce effective reagents to carry out various diagnostic tests. The additional funding & investment for research from government agencies and non-profit organizations. For instance, as per India Brand Equity Foundation (IBEF), in May 2020, the Department of Biotechnology received Rs. 2,581 crores (USD 343.56 million ) in the Union Budget 2022–23 for the development of fundamental infrastructure, genetic engineering, technologies and bioinformatics, agricultural biotechnology, and training qualified professionals.
• Some of the major players operating in the market include Merck KGaA; Thermo Fisher Scientific Inc.; Bio-RAD Laboratories Inc.; Tecan Trading AG.; Agilent Technologies Inc.; Hamilton Company; Promega Corporation; Illumina Inc.; F. Hoffmann-La Roche Ltd; Danaher.